Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Peter MD

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Peter MD head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 61 · Grade C

Peter MD

Visit Peter MD Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 76 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Peter MD a bad call — it's best for readers who want glp-1 care bundled with trt, sermorelin, nad+ or hair-loss treatment on a single account, and are comfortable reading a tiered price ladder rather than one flat monthly figure this site can map straight onto a dose. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
76
Supply Reliability
95
82
Transparency
90
65
Access Breadth
93
78
Clinical Oversight
92
82
Track Record
88
74
CoreAge RxBrief Score 94 · 76Peter MD

Price, coverage & the tracker

CoreAge RxPeter MD
Brief Score94/100 (A)76/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$149/mo new-user tier · $139/mo returning-user tier (GLP1 + B12)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$249/mo after a $149 first month (billed quarterly, 60mg)

CoverageUS only; restrictions by state, confirmed at intakeMost states — exclusions vary by treatment (not a single list)
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Peter MD: Tirzepatide starts at $149 for the first month, then $249 on quarterly billing. Compounded semaglutide with B12 has separate $149 new-user and $139 returning-user monthly tiers.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.